# Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/acarbose-for-prevention-of-type-2-diabetes-mellitus-the-stop-niddm-randomised/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jean‐Louis Chiasson,Robert G. Josse,Ramón Gomis,M Hanefeld,Avraham Karasik,Markku Laakso |
| Citations | 2,550 |
| DOI | 10.1016/s0140-6736(02)08905-5 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2123744385 |
| PMID | 12086760 |
| Type | article |
| Year | 2002 |

## Paper authors

- [Robert G. Josse](https://scholariq.org/researchers/robert-g-josse/)

## Paper journal

- [The Lancet](https://scholariq.org/journals/the-lancet/)

## Paper primary topic

- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)

## Paper topics

- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Natural Antidiabetic Agents Studies](https://scholariq.org/topics/natural-antidiabetic-agents-studies/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.